CEACAM5 and cancer: The tumor markers of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19.9) are not diagnostic tests and are used for monitoring patients with CRC, mostly after curative surgical interventions, and are used primarily to detect early cancer recurrence [36,37,38,39].